A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Incyte Corporation
Sotio Biotech Inc.
Xencor, Inc.
Xencor, Inc.
Genocea Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center